TYRA Insider Trading Activity and SEC Form 4 Filings
TYRA insider trading summary
Over the past 12 months, insiders at Tyra Biosciences, Inc. (TYRA) reported 11 sales worth $9.8M by 2 insiders and 1 open-market purchase worth $20K by 1 insider on SEC Form 4. Net insider selling was $9.8M.
Latest TYRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Rehan Verjee | Insider | Buy | $20K (971.894 @ $20.58) |
| Jan 12, 2026 | Daniel Bensen | Chief Discovery Officer | Sell | $30K (1,017 @ $29.08) |
| Jan 12, 2026 | Daniel Bensen | Chief Discovery Officer | Sell | $199K (6,983 @ $28.44) |
| Dec 19, 2025 | Robert J More | Insider | Sell | $250K (10,000 @ $25.00) |
| Dec 12, 2025 | Daniel Bensen | Chief Discovery Officer | Sell | $181K (8,000 @ $22.64) |
| Nov 21, 2025 | Robert J More | Insider | Sell | $5.0M (246,871 @ $20.25) |
| Nov 19, 2025 | Daniel Bensen | Chief Operating Officer | Sell | $815K (49,956 @ $16.32) |
| Nov 18, 2025 | Daniel Bensen | Chief Operating Officer | Sell | $1.2M (75,633 @ $16.07) |
| Nov 17, 2025 | Daniel Bensen | Chief Operating Officer | Sell | $299K (18,572 @ $16.11) |
| Nov 17, 2025 | Daniel Bensen | Chief Operating Officer | Sell | $26K (1,500 @ $17.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.